STAT+: Pharmalittle: We’re reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and more

<iframe
  src="https://statesidedaily.com/embed/cluster/faa0eb95def5179aca439c70696350bc5604549c"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Pharmalittle: We&#8217;re reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and more"></iframe>